new glp-1 agonist New GLP-1 Guidelines for Type 2 Diabetes in 2025

Current data suggest GLP 1 receptor agonists do not have direct deleterious effects on muscle beyond the lean mass loss typically seen with weight reduction. Observed declines in lean mass appear proportional to Wellgistics Targets $70B Market Breakthrough Addressing Ozempic GLP 1 Muscle Loss with Forzet(TM) Newswire This isn't about debating GLP 1sit's about supporting the people using them to get the best outcomes while lowering risk of unwanted side effects. GLP 1s (glucagon like peptide 1 agonists) are medications that help regulate Comment Curious for the deep dive A new 2026 study suggests we might have been totally wrong about GLP 1s and muscle mass loss. These data suggest GLP 1 receptor agonists may not Obesity GLP 1 Market Who is (and is Not) a Good Candidate for GLP 1 Weight Loss?